U.S. License Holder:
Dr. Reddy's / Fresenius Kabi
Date of License:
aBLA accepted by FDA July-2023
Last Update:
Sep-23-2023
FDA-Approved Indications
DRL_RI (rituximab) is not FDA-approved. An aBLA has been accepted by the FDA.